United Therapeutics Operating Margin 2006-2019 | UTHR

Current and historical operating margin for United Therapeutics (UTHR) over the last 10 years. The current operating profit margin for United Therapeutics as of December 31, 2019 is -7.21%.
United Therapeutics Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2019-12-31 $1.45B $-0.19B -12.97%
2019-09-30 $1.52B $-0.12B -7.89%
2019-06-30 $1.53B $-0.15B -9.99%
2019-03-31 $1.60B $-0.16B -9.80%
2018-12-31 $1.63B $0.81B 49.51%
2018-09-30 $1.71B $0.81B 47.49%
2018-06-30 $1.75B $0.99B 56.56%
2018-03-31 $1.75B $0.86B 49.23%
2017-12-31 $1.73B $0.82B 47.25%
2017-09-30 $1.67B $0.85B 50.93%
2017-06-30 $1.63B $0.77B 46.91%
2017-03-31 $1.60B $0.96B 60.09%
2016-12-31 $1.60B $1.06B 66.42%
2016-09-30 $1.60B $1.04B 65.39%
2016-06-30 $1.57B $1.19B 75.72%
2016-03-31 $1.51B $1.08B 71.53%
2015-12-31 $1.47B $0.70B 47.68%
2015-09-30 $1.41B $0.72B 51.39%
2015-06-30 $1.35B $0.30B 22.50%
2015-03-31 $1.33B $0.31B 23.21%
2014-12-31 $1.29B $0.54B 41.85%
2014-09-30 $1.23B $0.33B 26.97%
2014-06-30 $1.20B $0.47B 38.99%
2014-03-31 $1.16B $0.42B 35.75%
2013-12-31 $1.12B $0.29B 26.23%
2013-09-30 $1.07B $0.45B 41.98%
2013-06-30 $1.01B $0.43B 42.09%
2013-03-31 $0.96B $0.41B 42.84%
2012-12-31 $0.92B $0.42B 46.18%
2012-09-30 $0.87B $0.36B 41.29%
2012-06-30 $0.83B $0.38B 45.95%
2012-03-31 $0.79B $0.39B 49.43%
2011-12-31 $0.74B $0.32B 42.74%
2011-09-30 $0.71B $0.27B 37.89%
2011-06-30 $0.68B $0.23B 33.68%
2011-03-31 $0.63B $0.18B 27.87%
2010-12-31 $0.59B $0.17B 28.62%
2010-09-30 $0.53B $0.15B 28.81%
2010-06-30 $0.46B $0.10B 22.44%
2010-03-31 $0.41B $0.04B 9.31%
2009-12-31 $0.36B $0.03B 7.52%
2009-09-30 $0.34B $-0.11B -31.16%
2009-06-30 $0.32B $-0.10B -31.43%
2009-03-31 $0.30B $-0.08B -25.33%
2008-12-31 $0.28B $-0.08B -29.08%
2008-09-30 $0.27B $0.04B 16.54%
2008-06-30 $0.25B $0.04B 16.00%
2008-03-31 $0.23B $0.03B 12.45%
2007-12-31 $0.21B $0.01B 2.84%
2007-09-30 $0.20B $0.02B 9.14%
2007-06-30 $0.18B $0.02B 8.43%
2007-03-31 $0.17B $0.02B 11.45%
2006-12-31 $0.16B $0.03B 18.24%
2006-09-30 $0.14B $0.04B 24.48%
2006-06-30 $0.14B $0.04B 28.68%
2006-03-31 $0.13B $0.04B 30.16%
2005-12-31 $0.12B $0.04B 37.07%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.038B $1.449B
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability. The company's product candidates include Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability in PAH patients. Orenitram is a prostacyclin vasodilator indicated for treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $55.999B 32.39
Takeda Pharmaceutical (TAK) Japan $47.260B 8.28
Astellas Pharma (ALPMY) Japan $27.822B 13.90
Eisai (ESALY) Japan $20.849B 38.84
Grifols, S.A (GRFS) Spain $13.421B 16.68
Merck (MKGAF) Germany $12.451B 16.33
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.539B 237.23
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.384B 30.38
Ionis Pharmaceuticals (IONS) United States $6.926B 20.99
Jazz Pharmaceuticals (JAZZ) Ireland $5.655B 6.90
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.299B 0.00
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.549B 0.00
IPSEN SA ADR (IPSEY) France $4.173B 0.00
Hypermarcas (HYPMY) Brazil $3.970B 12.08
Evotec AG (EVTCY) Germany $3.485B 56.21
Arrowhead Pharmaceuticals (ARWR) United States $3.110B 57.72
Nektar Therapeutics (NKTR) United States $3.109B 0.00
FibroGen (FGEN) United States $2.976B 0.00
PTC Therapeutics (PTCT) United States $2.720B 0.00
ChemoCentryx (CCXI) United States $2.460B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.375B 9.61
Xencor (XNCR) United States $1.725B 70.44
Sage Therapeutics (SAGE) United States $1.607B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.595B 19.39
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.578B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.467B 0.00
Karyopharm Therapeutics (KPTI) United States $1.392B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.364B 37.29
USANA Health Sciences (USNA) United States $1.344B 14.11
Corcept Therapeutics (CORT) United States $1.261B 14.10
CLINIGEN GP (CLIGF) United Kingdom $1.103B 0.00
Heron Therapeutics (HRTX) United States $1.084B 0.00
Zogenix (ZGNX) United States $1.074B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.032B 14.38
Esperion Therapeutics (ESPR) United States $1.029B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.991B 30.69
Akebia Therapeutics (AKBA) United States $0.977B 0.00
Endo (ENDP) Ireland $0.855B 1.58
Tilray (TLRY) Canada $0.822B 0.00
Radius Health (RDUS) United States $0.666B 0.00
Molecular Templates (MTEM) United States $0.658B 0.00
Aerie Pharmaceuticals (AERI) United States $0.627B 0.00
ImmunoGen (IMGN) United States $0.617B 0.00
Translate Bio (TBIO) United States $0.615B 0.00
Collegium Pharmaceutical (COLL) United States $0.583B 0.00
Portola Pharmaceuticals (PTLA) United States $0.551B 0.00
Indivior (INVVY) United States $0.509B 3.03
Corbus Pharmaceuticals Holdings (CRBP) United States $0.405B 0.00
Siga Technologies (SIGA) United States $0.402B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.402B 13.41
Ardelyx (ARDX) United States $0.395B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.390B 15.99
Innate Pharma SA (IPHYF) France $0.385B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.385B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.374B 0.00
Organogenesis Holdings (ORGO) United States $0.373B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.352B 0.00
TherapeuticsMD (TXMD) United States $0.350B 0.00
Flexion Therapeutics (FLXN) United States $0.337B 0.00
Trillium Therapeutics (TRIL) Canada $0.325B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.307B 0.00
Harpoon Therapeutics (HARP) United States $0.301B 0.00
DURECT (DRRX) United States $0.294B 0.00
Lannett Co Inc (LCI) United States $0.291B 4.69
Calithera Biosciences (CALA) United States $0.289B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.284B 0.00
Concert Pharmaceuticals (CNCE) United States $0.273B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.270B 0.00
Ocular Therapeutix (OCUL) United States $0.257B 0.00
CASI Pharmaceuticals (CASI) United States $0.222B 0.00
OptiNose (OPTN) United States $0.191B 0.00
Rafael Holdings (RFL) United States $0.189B 0.00
Recro Pharma (REPH) United States $0.179B 0.00
Nature's Sunshine Products (NATR) United States $0.177B 22.15
MEI Pharma (MEIP) United States $0.171B 0.00
Jounce Therapeutics (JNCE) United States $0.170B 3.07
PROFOUND MEDICL (PROF) Canada $0.156B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.154B 0.00
KalVista Pharmaceuticals (KALV) United States $0.137B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.135B 0.00
Taiwan Liposome (TLC) Taiwan $0.128B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.106B 0.00
CannTrust Holdings (CTST) Canada $0.105B 0.00
Redhill Biopharma (RDHL) Israel $0.097B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.092B 0.00
IMV INC (IMV) Canada $0.087B 0.00
Xeris Pharmaceuticals (XERS) United States $0.086B 0.00
VAXART, INC (VXRT) United States $0.081B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.079B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.078B 0.00
Champions Oncology (CSBR) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.075B 0.00
SCYNEXIS (SCYX) United States $0.075B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.073B 0.00
CV Sciences (CVSI) United States $0.071B 0.00
CTI BioPharma (CTIC) United States $0.068B 0.00
Aquestive Therapeutics (AQST) United States $0.068B 0.00
Biomerica (BMRA) United States $0.065B 0.00
Otonomy (OTIC) United States $0.063B 0.00
Hemispherx BioPharma (AIM) United States $0.058B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.058B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.056B 17.62
Infinity Pharmaceuticals (INFI) United States $0.054B 0.00
PharmAthene (ALT) United States $0.050B 0.00
Aclaris Therapeutics (ACRS) United States $0.049B 0.00
PolarityTE (PTE) United States $0.048B 0.00
MediWound (MDWD) Israel $0.046B 0.00
Onconova Therapeutics (ONTX) United States $0.045B 0.00
Nivalis Therapeutics (ALPN) United States $0.045B 0.00
GTx (ONCT) United States $0.043B 0.00
Natural Alternatives (NAII) United States $0.042B 19.19
AgeX Therapeutics (AGE) United States $0.042B 0.00
Neos Therapeutics (NEOS) United States $0.041B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 131.29
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
IsoRay (ISR) United States $0.039B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.038B 0.00
Heat Biologics (HTBX) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.026B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.025B 0.00
India Globalization Capital (IGC) United States $0.025B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
Mannatechorporated (MTEX) United States $0.024B 7.55
Bellicum Pharmaceuticals (BLCM) United States $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Novan (NOVN) United States $0.020B 0.00
China SXT Pharmaceuticals (SXTC) China $0.017B 0.00
Bio-Path Holdings (BPTH) United States $0.014B 0.00
ElectroCore (ECOR) United States $0.014B 0.00
Vical (BBI) United States $0.012B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Can-Fite Biopharma (CANF) Israel $0.012B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Shineco (TYHT) China $0.011B 0.00
KemPharm (KMPH) United States $0.011B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Midatech Pharma (MTP) United Kingdom $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.005B 0.00
HANCOCK JAFFE (HJLI) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.003B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00